Cefot, made by Advanced Chemical Industries PLC, is a 500 mg/vial injection containing the antibiotic cefotaxime. It is given by healthcare professionals for certain bacterial infections.
There are 24 brands of Cefotaxime listed in Bangladesh. 10 of them have a lower unit price than Cefot. The lowest listed price is Cefot 250 mg/vial IV/IM Injection at ৳ 50.15 per unit.
What is Cefot 500 mg/vial IV/IM Injection?
Cefot is an injection supplied as a 500 mg vial. Its active ingredient is cefotaxime, a third-generation cephalosporin antibiotic that is given into a vein or muscle by a healthcare professional. It belongs to a group of medicines used to treat infections caused by bacteria. Because it is an injected antibiotic, it is handled and given by trained staff rather than used at home. The doctor decides whether it is suitable, the dose and how long the course lasts. Tell your doctor about any allergy to antibiotics before treatment begins.
Uses of Cefot
Cefot is used to treat bacterial infections, including infections of the blood (septicaemia) and of the respiratory tract such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis and lung abscess. It can be started before the exact bacterium is identified, or when the infection is known to be caused by bacteria that respond to cefotaxime. Only a doctor can decide whether it is the right antibiotic for a particular infection.
How to use Cefot
Cefot comes as a powder in a vial that is made up into a solution and given as an injection into a vein or a muscle. This is done by a doctor or nurse, not by the patient. The doctor decides the dose, how often it is given and how long the course lasts, based on the infection and the person's condition. The prepared solution should be used as directed by the healthcare team and stored as the label advises.
Side effects of Cefot
Side effects are reported relatively infrequently and are usually mild and short-lived. They include candidiasis, rashes, fever, diarrhoea and short-term rises in liver enzymes. Rarely, a serious bowel problem called pseudomembranous colitis can occur with cephalosporins; if severe diarrhoea develops, treatment should be stopped and the doctor contacted. High doses, especially in people with kidney problems, have rarely been linked to changes in kidney function and to brain-related effects. Tell the healthcare team about any reaction.
Safety and precautions
Cefot must not be given to anyone who has had a hypersensitivity reaction to cefotaxime or to other cephalosporin antibiotics. It should be used with caution in people with a history of gastrointestinal disease, particularly colitis, and in those with reduced kidney function, where the doctor may adjust the dose. Safety in human pregnancy has not been established, so it should not be used in pregnancy, especially the first trimester, unless the expected benefit is weighed against possible risks; it passes into breast milk. Ask your doctor first if you are pregnant, breastfeeding, have kidney problems, or have any antibiotic allergy.
Frequently asked questions
What does the 500 mg/vial strength and injection form mean?
Each vial contains 500 mg of cefotaxime as a powder. It is made up into a solution and given as an injection into a vein or muscle by a healthcare professional. The doctor decides the dose and course.
What is Cefot used for and what kind of medicine is it?
Cefot is a third-generation cephalosporin antibiotic given by injection. It is used for bacterial infections such as septicaemia and respiratory tract infections including bronchitis, bacterial pneumonia, infected bronchiectasis and lung abscess. A doctor decides whether it suits your infection.
Which medicines may interact with Cefot?
Increased kidney toxicity has been reported when cephalosporins are given together with aminoglycoside antibiotics. Tell your doctor or pharmacist about all medicines you take, including any other antibiotics, so they can check for interactions and decide what is appropriate.
Who should ask a doctor before receiving Cefot?
Anyone with a known allergy to cefotaxime or cephalosporins, a history of gastrointestinal disease such as colitis, kidney problems, or who is pregnant or breastfeeding should speak to the doctor first. The doctor will weigh the benefits and risks before prescribing.
Cefotaxime is indicated for the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity: Septicaemia Respiratory Tract Infections such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis ... Read moreCefotaxime is indicated for the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity: Septicaemia Respiratory Tract Infections such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis, lung abscess and postoperative chest infections Urinary Tract Infections such as acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria Soft-tissue Infection such as cellulitis, peritonitis and wound infections Bone and Joint Infections such as osteomyelitis, septic arthritis Obstetric and gynaecological infections: such as pelvic inflammatory disease Gonorrhoea particularly when penicillin has failed or is unsuitable Other Bacterial Infections: meningitis and other sensitive infections suitable for parenteral antibiotic therapy Prophylaxis: The administration of Cefotaxime prophylactically may reduce the incidence of certain post operative infections in patients undergoing surgical procedures that are classified as contaminated or potentially contaminated or in clean operation where infection would have serious effects.
Pharmacology
Cefotaxime binds to 1 or more of the penicillin binding proteins (PBPs) which inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death. Cefotaxime is a broad spectrum bactericidal 3rd generation parenteral cephalosporin antibiotic. Cefotaxime is exceptionally active against gram-negative organisms sensitive or resistant to first or second generation cephalosporins. It is similar to other cephalosporins in activity against gram-positive bacteria.
Dosage & Administration
Adults: The recommended dosage for mild to moderate infections is 1 gm every 12 hourly. However, dosage may be varied according to the severity of infection, sensitivity of causative organisms and condition of the patient. In severe infections dosage may be increased up to 12 gm daily given in 3 or 4 divided doses. For infections caused by sensitive Pseudomonas spp. daily doses of greater than 6 gm will usually be required
Children: The usual dosage range is 100-150 mg/kg/day in 2 to 4 divided doses. However, in very severe infections doses of up to 200 mg/kg/day may be required.
Neonates: The recommended dosage is 50 mg/kg/day in 2 to 4 divided doses. In severe infections 150-200 mg/kg/day, in divided doses, have been given.
Dosage in gonorrhoea: 500 mg as a single dose.
Interaction
Increased nephrotoxicity has been reported following concomitant administration of cephalosporins and aminoglycoside antibiotics.
Contraindications
Cefotaxime is contraindicated in patients who have shown hypersensitivity to cefotaxime or the cephalosporin group of antibiotics.
Side Effects
Adverse reactions to Cefotaxime have occurred relatively infrequently and have generally been mild and transient. Effects reported include candidiasis, rashes, fever, transient rises in liver transaminase and/or alkaline phosphatase and diarrhoea. As with all cephalosporins, pseudomembranous colitis may rarely occur during treatment. If this occurs the drug should be stopped and specific treatment instituted.As with other cephalosporins, changes in renal function have been rarely observed with high doses of Cefotaxime. Administration of high doses of cephalosporins particularly in patients with renal insufficiency may result in encephalopathy. Hypersensitivity reactions have been reported, these include skin rashes, drug fever and very rarely anaphylaxis.
Pregnancy & Lactation
Although studies in animals have not shown any adverse effect on the developing foetus, the safety of Cefotaxime in human pregnancy has not been established. Consequently, Cefotaxime should not be administered during pregnancy especially during first trimester, without carefully weighing the expected benefit against possible risks. Cefotaxime is excreted in the milk.
Precautions & Warnings
Cefotaxime should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. Because high and prolonged antibiotic concentrations can occur from usual doses in patients with transient or persistent reduction of urinary output because of renal insufficiency, the total daily dosage should be reduced when Cefotaxime is administered to such patients. Continued dosage should be determined by degree of renal impairment, severity of infection, and susceptibility of the causative organism. There is no clinical evidence supporting the necessity of changing the dosage of Cefotaxime in patients with even profound renal dysfunction.
Storage Conditions
Store below 25°C, protected from light and moisture. Use reconstituted solution immediately. Reconstituted solution is stable for up to 24 h if stored between 2° to 8°C.
Alternative brands of Cefotaxime
Other brands with the same generic name, cheapest first.